Vanda Pharmaceuticals Inc. (VNDA)

17.00
NASDAQ : Health Technology
Prev Close 16.90
Day Low/High 16.75 / 17.10
52 Wk Low/High 11.90 / 20.40
Avg Volume 727.10K
Exchange NASDAQ
Shares Outstanding 52.11M
Market Cap 875.46M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Vanda Pharmaceuticals Reports Preliminary Fourth Quarter And Full Year 2017 Revenue Results And 2018 Guidance

Vanda Pharmaceuticals Reports Preliminary Fourth Quarter And Full Year 2017 Revenue Results And 2018 Guidance

- 2017 Total revenues are expected to be approximately $165 million

VNDA Makes Notable Cross Below Critical Moving Average

VNDA Makes Notable Cross Below Critical Moving Average

In trading on Friday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $15.29, changing hands as low as $15.15 per share. Vanda Pharmaceuticals Inc shares are currently trading down about 1.9% on the day.

First Week of February 2018 Options Trading For Vanda Pharmaceuticals (VNDA)

First Week of February 2018 Options Trading For Vanda Pharmaceuticals (VNDA)

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the February 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new February 2018 contracts and identified one put and one call contract of particular interest.

Interesting VNDA Put And Call Options For January 2018

Interesting VNDA Put And Call Options For January 2018

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the January 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new January 2018 contracts and identified one put and one call contract of particular interest.

Relative Strength Alert For Vanda Pharmaceuticals

Relative Strength Alert For Vanda Pharmaceuticals

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Vanda Pharmaceuticals Enters Oversold Territory (VNDA)

Vanda Pharmaceuticals Enters Oversold Territory (VNDA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Vanda Pharmaceuticals (VNDA) Shares Cross Below 200 DMA

Vanda Pharmaceuticals (VNDA) Shares Cross Below 200 DMA

In trading on Thursday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $15.26, changing hands as low as $14.65 per share. Vanda Pharmaceuticals Inc shares are currently trading off about 5.5% on the day.

Interesting VNDA Put And Call Options For November 17th

Interesting VNDA Put And Call Options For November 17th

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the November 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new November 17th contracts and identified one put and one call contract of particular interest.

Summit Therapeutics Stock Gets Smoked After IPO Pricing

Summit Therapeutics Stock Gets Smoked After IPO Pricing

Summit Therapeutics and Epizyme are raising cash to fund new drug development.

Vanda Pharmaceuticals (VNDA) Shares Cross Above 200 DMA

In trading on Tuesday, shares of Vanda Pharmaceuticals Inc crossed above their 200 day moving average of $15.01, changing hands as high as $15.30 per share. Vanda Pharmaceuticals Inc shares are currently trading up about 8.2% on the day.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADGE, ANTX, HY, RTRX, VNDA Downgrades: CELP, FORD, GRC, HMSY, LNCE, MET, NCI, OUT, PLPC, UBA Initiations: ADAP, DGLT Read on to get TheStreet Quant Ratings' detailed report:

First Week of May 19th Options Trading For Vanda Pharmaceuticals (VNDA)

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the May 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new May 19th contracts and identified one put and one call contract of particular interest.

VNDA Makes Notable Cross Below Critical Moving Average

In trading on Monday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $14.20, changing hands as low as $14.10 per share. Vanda Pharmaceuticals Inc shares are currently trading off about 1.4% on the day.

VNDA Crosses Below Key Moving Average Level

In trading on Thursday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $13.75, changing hands as low as $13.55 per share. Vanda Pharmaceuticals Inc shares are currently trading off about 1.1% on the day.

First Week of April 21st Options Trading For Vanda Pharmaceuticals

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new April 21st contracts and identified one put and one call contract of particular interest.

VNDA Crosses Below Key Moving Average Level

VNDA Crosses Below Key Moving Average Level

In trading on Monday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $13.24, changing hands as low as $13.00 per share. Vanda Pharmaceuticals Inc shares are currently trading off about 1.5% on the day.

Vanda Pharmaceuticals is Now Oversold (VNDA)

Vanda Pharmaceuticals is Now Oversold (VNDA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting VNDA Put And Call Options For February 17th

Interesting VNDA Put And Call Options For February 17th

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the February 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new February 17th contracts and identified one put and one call contract of particular interest.

Short Interest In Vanda Pharmaceuticals Falls 10.2%

Short Interest In Vanda Pharmaceuticals Falls 10.2%

The most recent short interest data has been released for the 11/15/2016 settlement date, which shows a 299,736 share decrease in total short interest for Vanda Pharmaceuticals Inc , to 2,633,513, a decrease of 10.22% since 10/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Short Interest In Vanda Pharmaceuticals Increases 10.2%

Short Interest In Vanda Pharmaceuticals Increases 10.2%

The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 272,221 share increase in total short interest for Vanda Pharmaceuticals Inc , to 2,933,249, an increase of 10.23% since 10/14/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Vanda Pharmaceuticals is Now Oversold (VNDA)

Vanda Pharmaceuticals is Now Oversold (VNDA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Buy Vanda Pharmaceuticals At $12, Earn 12.7% Annualized Using Options

Commit To Buy Vanda Pharmaceuticals At $12, Earn 12.7% Annualized Using Options

Investors considering a purchase of Vanda Pharmaceuticals Inc stock, but tentative about paying the going market price of $15.00/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June 2017 put at the $12 strike, which has a bid at the time of this writing of 95 cents.

Notable Thursday Option Activity: VNDA, AIRM, LL

Notable Thursday Option Activity: VNDA, AIRM, LL

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Vanda Pharmaceuticals Inc , where a total volume of 13,322 contracts has been traded thus far today, a contract volume which is representative of approximately 1.3 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 127.7% of VNDA's average daily trading volume over the past month, of 1.0 million shares.

Vanda Pharma (VNDA) Stock Price Target Upped on Drug Patent Ruling

Vanda Pharma (VNDA) Stock Price Target Upped on Drug Patent Ruling

JMP Securities increased Vanda Pharma's (VNDA) stock price target to $22 from $18 after a judge ruled that a generic drug maker's medication violated the company's patents.

Vanda Pharmaceuticals Stock Sees Short Interest Fall 13%

Vanda Pharmaceuticals Stock Sees Short Interest Fall 13%

The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 396,865 share decrease in total short interest for Vanda Pharmaceuticals Inc , to 2,647,162, a decrease of 13.04% since 07/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

TheStreet Quant Rating: C (Hold)